I'm LongbridgeAI, I can summarize articles.Dawnrays Pharma (2348.HK) slipped nearly 2% in Hong Kong trading to HK$0.8650, hitting a 52-week low intraday.
The stock is down 4.95% over the past ten sessions and down 25.24% year to date. It sits 27.13% below its 52-week high of HK$1.187. Volume was 6.11 times its average.
The Hang Seng Index is down 5.46% over the past five sessions and down 12.81% year to date.
The pharmaceuticals industry index fell 4.2% over the same period.
Based on public media reports. AI-generated; not investment advice.
